Background: Neonatal cerebral venous thrombosis (CVT) is a cerebrovascular disorder, cause of 20% of cases of perinatal stroke, with an incidence from 1 to 12/100000 live births. Although neonatal CVT has been the subject of numerous studies, preterm infants have long been underrepresented: many cohorts were restricted to term neonates or included too few preterm infants to allow a separate analysis. Aims: the aim of this study was to compare term and preterm neonates with cerebral venous thrombosis enrolled in the Italian Registry of Infantile Thrombosis (RITI), with focus on epidemiological, clinical and neuroradiological features, underlying comorbidities and risk factors, treatment and outcome at discharge and at the last follow-up. Methods: This was an observational, longitudinal, retrospective study. Data collection was conducted using RITI, a national multicenter observational registry for patients with episodes of cerebral and systemic thromboembolism (arterial or venous), in pediatric or neonatal age. Term and preterm infants diagnosed with neonatal CVT (within 28 days of birth) were included. Demographics characteristic, risk factors, clinical presentation, diagnostic procedures, antithrombotic therapy and outcome were analysed and compared between term and preterm neonates. Prognostic predictors of neurological outcome at last follow-up and the association between different clinical, neuroradiological and treatment features were investigated with regression logistic analysis in the overall cohort. Results: 89 neonates were included: 61 term and 28 preterm, 62% male, with a median gestational age at birth of 39 weeks in term and 34 weeks in preterm infants. Median age at diagnosis was 5 days for term versus 9 days for preterm infants. Symptomatic term infants at onset were more frequent than preterm ones (93% versus 64%) and 90% of term newborns showed at least one sign of encephalopathy, including seizures, versus 61% of preterm patients. Most frequent thrombosis sites were the transverse sinuses (56%), the deep medullary veins (44%) and the superior sagittal sinus (18%), while thrombosis associated lesions were mostly hemorrhages (58%). and venous infarction (44%). 41% of patients received antithrombotic treatment, mostly low molecular weight heparin (89%), and only one patient presented treatment-related bleeding. Neurological disabilities were observed in 46,4% of patients at last follow-up. No significant differences were observed between term and preterm infants in risk factors, neuroradiological features, treatment and outcome. Thrombosis-related brain lesions were associated with neurological disability at last follow-up (aOR 5.09, 95% CI 1.53–20.1, p=0,007), and venous infarction with seizures at onset (aOR 3.83, 95% CI 1.54–10.1, p=0,004), in both univariable and multivariable analyses. Anticoagulation was associated with lower odds of neurological disability only at univariable analysis. Intracranial hemorrhages at diagnosis were not associated with the decision to start anticoagulant therapy. Conclusions: in this national registry cohort, neonatal CVT in preterm infants differed from that in term infants mainly in the timing and mode of presentation, likely reflecting the subtle neurological signs and medical complexity of preterm patients. Risk factors, comorbidities, neuroradiological features, treatment and outcome were similar between groups. Thrombosis-related brain lesions were the strongest predictor of adverse neurological outcome at last follow-up. Neither gestational age nor the presence of intracranial hemorrhage was associated with the decision to start anticoagulant therapy, both in term and in preterm infants, and no significant treatment-related complications occurred. Randomized controlled trials and specific recommendations are needed to guide anticoagulant treatment in neonatal age, especially for preterm infants.

CEREBRAL VENOUS THROMBOSIS IN TERM VERSUS PRETERM NEONATES: DATA FROM THE ITALIAN REGISTRY OF INFANTILE THROMBOSIS (RITI)

FRASSON, LIVIANA
2024/2025

Abstract

Background: Neonatal cerebral venous thrombosis (CVT) is a cerebrovascular disorder, cause of 20% of cases of perinatal stroke, with an incidence from 1 to 12/100000 live births. Although neonatal CVT has been the subject of numerous studies, preterm infants have long been underrepresented: many cohorts were restricted to term neonates or included too few preterm infants to allow a separate analysis. Aims: the aim of this study was to compare term and preterm neonates with cerebral venous thrombosis enrolled in the Italian Registry of Infantile Thrombosis (RITI), with focus on epidemiological, clinical and neuroradiological features, underlying comorbidities and risk factors, treatment and outcome at discharge and at the last follow-up. Methods: This was an observational, longitudinal, retrospective study. Data collection was conducted using RITI, a national multicenter observational registry for patients with episodes of cerebral and systemic thromboembolism (arterial or venous), in pediatric or neonatal age. Term and preterm infants diagnosed with neonatal CVT (within 28 days of birth) were included. Demographics characteristic, risk factors, clinical presentation, diagnostic procedures, antithrombotic therapy and outcome were analysed and compared between term and preterm neonates. Prognostic predictors of neurological outcome at last follow-up and the association between different clinical, neuroradiological and treatment features were investigated with regression logistic analysis in the overall cohort. Results: 89 neonates were included: 61 term and 28 preterm, 62% male, with a median gestational age at birth of 39 weeks in term and 34 weeks in preterm infants. Median age at diagnosis was 5 days for term versus 9 days for preterm infants. Symptomatic term infants at onset were more frequent than preterm ones (93% versus 64%) and 90% of term newborns showed at least one sign of encephalopathy, including seizures, versus 61% of preterm patients. Most frequent thrombosis sites were the transverse sinuses (56%), the deep medullary veins (44%) and the superior sagittal sinus (18%), while thrombosis associated lesions were mostly hemorrhages (58%). and venous infarction (44%). 41% of patients received antithrombotic treatment, mostly low molecular weight heparin (89%), and only one patient presented treatment-related bleeding. Neurological disabilities were observed in 46,4% of patients at last follow-up. No significant differences were observed between term and preterm infants in risk factors, neuroradiological features, treatment and outcome. Thrombosis-related brain lesions were associated with neurological disability at last follow-up (aOR 5.09, 95% CI 1.53–20.1, p=0,007), and venous infarction with seizures at onset (aOR 3.83, 95% CI 1.54–10.1, p=0,004), in both univariable and multivariable analyses. Anticoagulation was associated with lower odds of neurological disability only at univariable analysis. Intracranial hemorrhages at diagnosis were not associated with the decision to start anticoagulant therapy. Conclusions: in this national registry cohort, neonatal CVT in preterm infants differed from that in term infants mainly in the timing and mode of presentation, likely reflecting the subtle neurological signs and medical complexity of preterm patients. Risk factors, comorbidities, neuroradiological features, treatment and outcome were similar between groups. Thrombosis-related brain lesions were the strongest predictor of adverse neurological outcome at last follow-up. Neither gestational age nor the presence of intracranial hemorrhage was associated with the decision to start anticoagulant therapy, both in term and in preterm infants, and no significant treatment-related complications occurred. Randomized controlled trials and specific recommendations are needed to guide anticoagulant treatment in neonatal age, especially for preterm infants.
2024
CEREBRAL VENOUS THROMBOSIS IN TERM VERSUS PRETERM NEONATES: DATA FROM THE ITALIAN REGISTRY OF INFANTILE THROMBOSIS (RITI)
venous thrombosis
cerebral
neonates
File in questo prodotto:
File Dimensione Formato  
Frasson_Liviana.pdf

Accesso riservato

Dimensione 9.43 MB
Formato Adobe PDF
9.43 MB Adobe PDF

The text of this website © Università degli studi di Padova. Full Text are published under a non-exclusive license. Metadata are under a CC0 License

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.12608/120639